Antibody Treatment May Be Less Effective On Omicron: US Biotech Firm

US biotech firm Regeneron said Tuesday that its synthetic antibody treatment for Covid-19 may be less effective against the new variant, and it plans to conduct tests to determine by how much.

from NDTV News - Latest https://ift.tt/31iRNjC

Comments

Popular posts from this blog

"Modi Does What He Promises": PM On Why People Trust His 'Guarantees'

'800-Strong Mob Intended To Cause Death': Probe Agency On Bengal Attack